Evidence map›Paper›PMID 40100388›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

Correction to: Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine‑induced hypo‑vascularization.

Irina Heid, Marija Trajkovic-Arsic, Fabian Lohöfer, Georgios Kaissis, Felix N Harder, Moritz Mayer, Geoffrey J Topping, Friderike Jungmann, Barbara Crone, Moritz Wildgruber and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Irina HeidSchool of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany. Irina.Heid@tum.de.
Marija Trajkovic-ArsicDivision of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.
Fabian LohöferSchool of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany.
Georgios KaissisSchool of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany.
Felix N HarderSchool of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany.
Moritz MayerSchool of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany.
Geoffrey J ToppingSchool of Medicine, Department of Nuclear Medicine, Technical University of Munich, Munich, Germany.
Friderike JungmannSchool of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany.
Barbara CroneInstitute of Inorganic and Analytical Chemistry, University of Muenster, Muenster, Germany.
Moritz WildgruberInstitute of Clinical Radiology, University Hospital Muenster, Muenster, Germany.
Uwe KarstInstitute of Inorganic and Analytical Chemistry, University of Muenster, Muenster, Germany.
Lucia LiottaSchool of Medicine, Clinic and Policlinic of Internal Medicine II, Technical University of Munich, Munich, Germany.
Hana AlgülComprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany.
Hsi-Yu YenSchool of Medicine, Institute of Pathology, Technical University of Munich, Munich, Germany.
Katja SteigerSchool of Medicine, Institute of Pathology, Technical University of Munich, Munich, Germany.
Wilko WeichertSchool of Medicine, Institute of Pathology, Technical University of Munich, Munich, Germany.
Jens T SivekeDivision of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.
Marcus R MakowskiSchool of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany.
Rickmer F BrarenSchool of Medicine, Institute of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany. rbraren@tum.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40100388
PMCPMC12316714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.